Zobrazeno 1 - 5
of 5
pro vyhledávání: '"MESH: Thrombocythemia, Essential"'
Publikováno v:
Blood
Blood, 2014, 124 (26), pp.3964-3966. ⟨10.1182/blood-2014-06-583161⟩
Blood, 2014, 124 (26), pp.3964-3966. ⟨10.1182/blood-2014-06-583161⟩
Calreticulin (CALR) mutations have recently been reported in JAK2- and MPL-negative Myeloproliferative Neoplasms (MPN), particularly essential thrombocythemia (ET) and primary myelofibrosis (PMF).The clinical course of sporadic CALR-mutated patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a96a85c1c4fe15b3850adf39a332b70
https://doi.org/10.1182/blood-2014-06-583161
https://doi.org/10.1182/blood-2014-06-583161
Autor:
Matt Kalaycio, Mukta Arora, Joseph H. Antin, Joerg Halter, Richard T. Maziarz, Wael Saber, Matthew Carabasi, Kwang Woo Ahn, Harry C. Schouten, Vikas Gupta, Ann E. Woolfrey, Mahmoud Aljurf, Brian J. Bolwell, David L. Porter, Ian D. Lewis, Xiaochun Zhu, H. Joachim Deeg, Jean-Yves Cahn, Mary M. Horowitz, Philip L. McCarthy, Gregory A. Hale, Bipin N. Savani, Biju George, Mehdi Hamadani, Steven Z. Pavletic, Jorge E. Cortes, Ed Copelan, Baldeep Wirk, Karen K. Ballen
Publikováno v:
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, Elsevier, 2012, 18 (9), pp.1446-54. ⟨10.1016/j.bbmt.2012.03.009⟩
Biology of Blood and Marrow Transplantation, 18(9), 1446-1454. Elsevier Science
Biology of Blood and Marrow Transplantation, Elsevier, 2012, 18 (9), pp.1446-54. ⟨10.1016/j.bbmt.2012.03.009⟩
Biology of Blood and Marrow Transplantation, 18(9), 1446-1454. Elsevier Science
Allogeneic hematopoietic cell transplantation (HCT) is curative for selected patients with advanced essential thrombocythemia (ET) or polycythemia vera (PV). From 1990 to 2007, 75 patients with ET (median age 49 years) and 42 patients with PV (median
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::623a77dea852f4a22050b6106c0c5a93
https://hal.archives-ouvertes.fr/hal-00849698
https://hal.archives-ouvertes.fr/hal-00849698
Autor:
Pascal Mossuz, François Girodon, Sylvie Hermouet, A Bouamrani, François Berger, Eric Lippert, Praloran Vincent, Irène Dobo, Marie Arlotto, Jean-Yves Cahn
Publikováno v:
Experimental Hematology
Experimental Hematology, Elsevier, 2008, 36 (12), pp.1642-7. ⟨10.1016/j.exphem.2008.07.013⟩
Experimental Hematology, Elsevier, 2008, 36 (12), pp.1642-7. ⟨10.1016/j.exphem.2008.07.013⟩
International audience; OBJECTIVE: Previous studies have suggested that two subtypes of essential thrombocythemia (ET) could be separated on the basis of their JAK2 status (V617F-positive or V617F-negative), with a continuum between V617F-positive ET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4276c5d78ad1241539a38ec63a240ac
https://www.hal.inserm.fr/inserm-00410498
https://www.hal.inserm.fr/inserm-00410498
Autor:
Olivier Fardel, Pascale Beaucournu, Martine Escoffre-Barbe, Thierry Lamy, Thierry Fest, Bernard Grosbois, Laurence Amiot, Patrick Jego, Isabelle Grulois, Marc Bernard
Publikováno v:
American Journal of Hematology
American Journal of Hematology, 2006, 81 (7), pp.554-6. ⟨10.1002/ajh.20592⟩
American Journal of Hematology, Wiley, 2006, 81 (7), pp.554-6. ⟨10.1002/ajh.20592⟩
American Journal of Hematology, 2006, 81 (7), pp.554-6. ⟨10.1002/ajh.20592⟩
American Journal of Hematology, Wiley, 2006, 81 (7), pp.554-6. ⟨10.1002/ajh.20592⟩
International audience; Laboratory detection of spontaneous growth of colony-forming unit-megacaryocytes (CFU-MK), allowing us to distinguish essential thrombocythemia (ET) from reactive thrombocytosis, is therefore useful for the diagnostic of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e8145b359561f6aa8f7cb37ed51e62a
https://hal.science/hal-00699518
https://hal.science/hal-00699518
Autor:
Christophe Desterke, Marie-Caroline Le Bousse-Kerdilès, Brigitte Dupriez, Pierre Fenaux, Dominique Bordessoule, Hans Carl Hasselbalch, Thomas Stauffer Larsen, Jean François Viallard, Martin Griesshammer, Peter J. Campbell, Claire N. Harrison, John T. Reilly, Hartmut Döhner, Jean-Jacques Kiladjian, Konstanze Döhner, Rajko Kusec, Anthony R. Green, Niels Pallisgaard, Jean Briere, Stéphane Giraudier, Bernadette Guerton
Publikováno v:
Blood
Blood, American Society of Hematology, 2006, 107 (5), pp.2098-100. ⟨10.1182/blood-2005-08-3395⟩
Blood, 2006, 107 (5), pp.2098-100. ⟨10.1182/blood-2005-08-3395⟩
Blood, American Society of Hematology, 2006, 107 (5), pp.2098-100. ⟨10.1182/blood-2005-08-3395⟩
Blood, 2006, 107 (5), pp.2098-100. ⟨10.1182/blood-2005-08-3395⟩
International audience; Most patients with polycythemia vera and half with idiopathic myelofibrosis and essential thrombocythemia have an acquired V617F mutation in JAK2. Using sensitive polymerase chain reaction (PCR)-based methods, we genotyped 152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37f066a9fd220a4620d623f50ea7b2fd
https://hal.archives-ouvertes.fr/hal-00453286
https://hal.archives-ouvertes.fr/hal-00453286